Actelion Pharmaceuticals US, Inc.  

5000 Shoreline Court
Suite 200
South San Francisco,  CA  94080-1956

United States
  • Booth: 2211


Actelion, a leader in Pulmonary Arterial Hypertension, became a part of the Janssen Pharmaceutical Companies of Johnson & Johnson following its acquisition in June 2017. Actelion’s medicines have helped to expand and strengthen Janssen’s portfolio. Janssen has added Pulmonary Hypertension as a therapeutic area of focus to maintain the leadership position Actelion has built in this rare disease area.